TFRC and breast cancer: The overexpression of CD71 also correlates with a poor prognosis in some solid tumors such as breast cancer [19], hepatocellular carcinoma [20], cholangiocarcinoma [21], renal cell carcinoma [22] and pancreatic cancer [23].